MaSTherCell S.A. Announces Agreement for Catalent to Acquire the MaSTherCell Group of Companies

GOSSELIES, BELGIUM – February 3, 2020 — MaSTherCell S.A., a subsidiary of MaSTherCell Global, Inc., a subsidiary of Orgenesis Inc. (NASDQ: ORGS)  a technology-focused cell and gene therapy contract development and manufacturing partner to leading cell therapy innovators, today announced an agreement to acquire MaSTherCell Global that has been reached between the owners of MaSTherCell…

Continue reading "MaSTherCell S.A. Announces Agreement for Catalent to Acquire the MaSTherCell Group of Companies"